| Literature DB >> 29264628 |
J Wagner1, V Luber2, J F Lock1, U A Dietz1, S Lichthardt1, N Matthes1, K Krajinovic1, C-T Germer1,3, S Knop2,3, A Wiegering4,5.
Abstract
Every year 16 million operations are performed in Germany. Many patients have an autoimmune disorder, for example rheumatoid arthritis, psoriasis or chronic inflammatory bowel disease, which requires treatment. Immunosuppressants are widely applied. Physicians must make a risk-adapted decision whether the immunosuppressant medication can be continued perioperatively or if certain drugs must be paused and if so, with what risks. The handling of immunosuppressants during the perioperative period is very relevant as many patients, for example with rheumatoid arthritis are in need of a hip or knee replacement or patients with inflammatory bowel disease need an operation due to the chronic illness. The interruption of an immunosuppressant therapy should be discussed in an interdisciplinary board according to the underlying disease, because the continuation of immunosuppressants perioperatively can lead to an increased rate of complications, especially wound healing disorders. If a patient is on a glucocorticoid therapy the following must be considered: during the perioperative period the body has an increased demand for glucocorticoids due to the stress reaction. If glucocorticoids are administered in a dosage of more than 7.5 mg/day equivalent of prednisolone this stress reaction is inhibited. Thus, in these cases a perioperative substitution with hydrocortisone is recommended.Entities:
Keywords: Chronic medication; Glucocorticoids; Immunosuppressants; Perioperative period; Preoperative pause
Mesh:
Substances:
Year: 2018 PMID: 29264628 DOI: 10.1007/s00104-017-0529-6
Source DB: PubMed Journal: Chirurg ISSN: 0009-4722 Impact factor: 0.955